RUVBL1 and pancreatic neoplasm: We wondered whether the dependence of pancreatic tumours on the RUVBL1/2 complex is conveyed by high MYC expression, so we did a series of experiments using the RUVBL1/2 inhibitor CB-6644 to address this question.